Profit Or Loss [Abstract]

Redcare Pharmacy N.V. - Filing #5831390

Concept 2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
2,370,575,000 EUR
1,798,758,000 EUR
Other income
345,000 EUR
318,000 EUR
Profit (loss) from operating activities
38,987,000 EUR
17,295,000 EUR
Finance income
7,418,000 EUR
18,221,000 EUR
Finance costs
16,679,000 EUR
15,500,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
415,000 EUR
226,000 EUR
Profit (loss) before tax
47,833,000 EUR
14,348,000 EUR
Tax expense (income)
1,477,000 EUR
2,742,000 EUR
Profit (loss)
46,356,000 EUR
892,000 EUR
0 EUR
0 EUR
0 EUR
0 EUR
45,464,000 EUR
0 EUR
45,464,000 EUR
0 EUR
0 EUR
11,606,000 EUR
0 EUR
0 EUR
12,041,000 EUR
435,000 EUR
12,041,000 EUR
0 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
45,464,000 EUR
12,041,000 EUR
Profit (loss), attributable to non-controlling interests
892,000 EUR
435,000 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
2.27
0.73
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
2.27
0.73

Talk to a Data Expert

Have a question? We'll get back to you promptly.